Examiner: PENNINGTON, HALLIE NICOLE

Tech Center 1600 • Art Units: 1671

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

§101 Eligibility

§102 Novelty

50.0%

§103 Obviousness

§112 Clarity

App #	Title	Status	Assignee
18135484	VIRAL AND HOST BIOMARKERS FOR DETECTION, THERAPEUTIC EFFECTIVENESS, AND MONITORING OF CANCER LINKED TO SARS-CoV-2 AND HUMAN PAPILLOMA VIRUS	Non-Final OA	LifeGene-Biomarks, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.